It is Best for Mothers that Need Antidepressants to Remain on Them for the Duration of their Pregnancy if Possible by Camilliere, Mia et al.
It is best for mothers that need 
antidepressants, to remain on them for the 
duration of their pregnancy if possible.
Each pregnancy is unique and all decisions 
should be made under the care of a doctor.
Selective serotonin reuptake inhibitors (SSRIs) 
are commonly used to treat:
- Depression
- Anxiety
- OCD
- Bipolar disorder
Pregnancies exposed to
 SSRIs are sometimes 
associated with:
- Preterm birth
- Lower birth weight 
- Neonatal SSRI withdrawal syndrome
Mothers with untreated depression are 
more prone to:
- Postpartum depression, suicidal 
thoughts, and engagement in risky 
behaviors while pregnant (like 
drinking, smoking, and drug abuse). 
- Complications (such as preeclampsia)
It also has detrimental impacts on fetal & 
infant health since they are more likely to be 
born premature and/or at a lower birth 
weight. 
The long-term health of a 
mother will impact the health 
of the fetus and eventually 
their health during infancy, 
childhood, and adolescence. 
Sertraline (Zoloft) 
and nine other 
common SSRIs failed 
to be associated with 
any significant 
defects.
Fluoxetine(Prozac) is 
associated with right 
ventricular outflow tract 
obstruction. 
Paroxetine (Paxil) is 
associated with 
anencephaly, and atrial 
septal defects.
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